FOXP3 and neoplasm: Recently, growing evidence indicates that CD4+CD25+FOXP3+ regulatory T cells (Tregs) play a significant role in the control of tumor immunity, immune evasion and therapy resistance (Mandal et al., 2005; Bhattacharyya et al., 2010).